# PureTech Health to Present at 19th Annual Virtual Needham Healthcare Conference

- Link: https://www.directorstalkinterviews.com/puretech-health-to-present-at-19th-annual-virtual-needham-healthcare-conference/412812334
- Published: 2020-04-14T07:23:03+01:00
- Author: Giles Arbor

**PureTech Health plc** (LON:PRTC) have today announced that Daphne Zohar, founder
and chief executive officer, will present at the 19th Annual Virtual Needham Healthcare
Conference on Wednesday, 15 April, at 1:30 PM EDT. The conference is being held 
virtually, and a webcast of the presentation will be available on the Investors 
Relations section of the PureTech website at https://www.puretechhealth.com/reports-
presentations.

**About PureTech Health**

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing
and commercialising highly differentiated medicines for devastating diseases, including
intractable cancers, lymphatic and gastrointestinal diseases, central nervous system
disorders and inflammatory and immunological diseases, among others. The Company
has created a broad and deep pipeline through the expertise of its experienced research
and development team and its extensive network of scientists, clinicians and industry
leaders. This pipeline, which is being advanced both internally and through PureTech’s
Founded Entities, is comprised of 23 product candidates and one product that has
been cleared by the US Food and Drug Administration (FDA). All of the underlying
programmes and platforms that resulted in this pipeline of product candidates were
initially identified or discovered and then advanced by the PureTech team through
key validation points based on the Company’s unique insights into the biology of
the brain, immune and gut, or BIG, systems and the interface between those systems,
referred to as the BIG Axis.

Share on: